The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Men who have sex with men (MSM) in Asia Pacific have called on national governments to create PrEP implementation strategies to help stem the fast-growing HIV epidemic among MSM.
Access to antiretroviral treatment is worryingly low in West and Central Africa, with little priority given to HIV in the region, according to a report from Médecins Sans Frontières (MSF). Currently, just 24% of people have access to treatment in the region.
Negotiating the political minefield of global drug policy has left civil society and many progressive-thinking countries disappointed by the outcomes of last week’s United Nations General Assembly Special Session (UNGASS) on the World Drug Problem, and frustrated by the UNGASS process.
Doctors at Georgetown University in the USA have reported the first diagnosed case of Alzheimer’s disease in a person living with HIV. It was previously thought that HIV-related inflammation in the brain may prevent amyloid deposition – one of the likely causes of Alzheimer’s disease.
Cases of antibiotic resistant gonorrhoea are on the rise in England and spreading across the country, according to a statement issued by Public Health England (PHE) on Sunday.
Peru is the latest country to approve the use of the antiretroviral drug, Truvada, as pre-exposure prohpylaxis (PrEP) to prevent HIV among people at a high risk of infection.
Indian study that bridges the gap between evidence from a closely-monitored trial and evidence from global surveillance, by finding a clear correlation between treatment, viral suppression and HIV incidence in large populations.
Although more Ugandan men are seeking medical circumcision, the government is falling short of its 80 per cent target. This has led some health experts to ask if Uganda should adopt a new strategy to encourage more men to come forward.
UNAIDS update indicates that US$ 26.2 billion is required to build sufficient momentum by 2020, to end AIDS by 2030, compared to an earlier estimate of US$ 30 billion.